The short answer
A corporate investment team screens a startup in two passes: strategic fit first, then the ordinary tests of team, market, product and price. The deal is then defended with two cases, a financial case and a strategic case, because research since 1998 finds that corporate investors tend to pay more when their strategic reasons are weak. A good investment memo shows that any premium over market price is paid for something specific. We found no reliable public benchmark for how many deals a CVC reviews to close one, so track your own funnel.
Screen on strategy first
BCG’s study of corporate venturers advises leaders to decide whether the unit’s main aim is financial or strategic, and to define search fields that keep investments relevant (2018). The evidence supports putting strategy first. Gompers and Lerner (NBER, 1998), who studied more than 30,000 investments, found corporate investments about as successful as those of independent venture firms, and most successful where there was strategic overlap with the parent. Programs without a strategic focus were unstable and often stopped after few investments. Dushnitsky and Lenox (2005) found that investments made as a “window on technology” outperformed narrow financial investing.
The table sets out a screening list. It is TURN8’s own framework, built from the sources in this article. We did not find a published list of criteria used by named corporate investors.
| Test | Question to answer | Typical evidence |
|---|---|---|
| Strategic fit | Does it advance a named goal of the parent, such as a technology, a market or a supply need? | A one-line link to the mandate; a business-unit sponsor. |
| Team | Can this team execute and take on a corporate investor? | References, track record, how founders handle conflict. |
| Market | Is the market large enough and growing, and is timing right? | Customer calls, third-party data. |
| Product and technology | Does it work, and is the technology defensible? | Demo, technical review, intellectual property position. |
| Return | Can the investment reach the returns the mandate requires? | VC-method model and comparable deals. |
| Price and terms | Is the valuation defensible, and are the terms workable for founders and other investors? | Valuation range, term sheet review. |
Table 1. TURN8 editorial guide, drawing on BCG (2018), Gompers and Lerner (1998) and Dushnitsky and Lenox (2005).
Score two returns, not one
Most corporate venture units track both kinds of return. A Touchstone survey cited by Global Venturing found that 79% of respondents used internal rate of return (IRR) and 73% used total value to paid-in capital (TVPI), alongside strategic measures such as the share of portfolio companies working with the parent, proofs of concept, and time or money saved or earned (Global Venturing, 2023). About two thirds of respondents aimed for venture-level performance.
The evidence on whether strategic returns beat financial ones is mixed. A 2020 meta-analysis by Huang and Madhavan found that strategic gains for the corporate lead to its financial gains, but that strategic returns were not significantly larger than financial returns, and that helping a venture succeed can cost the corporate some financial return. Our reading is that an investment memo should state both cases openly and say which one carries the decision.
Price: why a corporate has to explain its premium
Gompers and Lerner found that corporate investors tend to pay a valuation premium. More recent figures relayed by Global Venturing from a GHIF and PitchBook report show early-stage CVC-backed deals priced at least 100% above market-wide pre-money figures between 2016 and 2023. Neither source proves a corporate overpays in any single deal, but both mean a committee should expect the question. If your price is above comparable deals, the memo should show what the extra amount buys: access, a commercial contract, exclusivity or a route to acquisition.
| Method | How it works | Limit |
|---|---|---|
| Berkus | Assigns up to $500,000 to each of five factors: idea, prototype, team, strategic relationships and early sales, giving a ceiling near $2.5 million pre-money. | Two angels can differ by about 30%. Suits pre-revenue companies only. |
| Scorecard | Starts from a regional median pre-money value and adjusts it by weighted factors: management 30%, market 25%, product 15%, competition 10%, sales and partnerships 10%, financing need 5%, other 5%. | Needs credible regional medians, which are scarce in the Gulf. |
| VC method | Discounts an expected exit value at a target return, commonly 30% to 60% a year at early stage, and adjusts for dilution. | Very sensitive to the exit assumption. |
| Comparables | Uses five to ten similar deals. | Multiples can move 30% to 50% within 18 months in many venture sectors, and early-stage comparables are scarce. |
Table 2. Source: Waveup, Startup valuation methods (reviewed 1 May 2026). Waveup is a secondary source; the Scorecard method is attributed to Bill Payne (2011) and the VC method to Sahlman (1987). Use at least two methods and compare.
Terms that matter to a corporate
Founders and co-investors look hard at the rights a corporate asks for. Startups.com lists the founder-side concerns: a right of first refusal on an acquisition, the signal that can deter other buyers, information rights that expose data to a potential competitor, and difficulty selling to the parent’s rivals (2026). A Morgan Lewis survey from 2020 found rights of first offer less common than other terms and rights of first refusal rarer still, with most liquidation preferences pari passu (81%) rather than senior (19%). Pro rata rights, which let an investor keep its ownership share in later rounds, usually go to larger “major” investors, according to CRV (2026). The Morgan Lewis data is a US survey and is old, so use it for direction only.
Our view is that a corporate often wins a founder’s preference by softening exclusivity and first-refusal rights and by agreeing a firewall on information. That is advice, not a finding. In the Gulf, some investors also need equity-only terms. Shariah screens commonly used for startups, as summarized by Wahed (2023), include a permissible core business, debt and cash below set limits, and no guaranteed returns or preferential liquidation. Wahed is a commercial source, not a ruling, so confirm with a Shariah board.
The investment memo and the committee
We found no authoritative public template for a corporate investment committee memo, so the outline below is TURN8’s own. It works because it forces the strategic case and the financial case onto the same page.
| Section | What it covers |
|---|---|
| Recommendation | The decision asked for, the amount, the stake and the terms. |
| Strategic case | The goal of the parent it serves, the business-unit sponsor and the commercial step planned. |
| Company and market | Team, product, customers, market size and competition. |
| Financial case | Valuation range by two or more methods, expected returns and the premium, if any, with its reason. |
| Diligence findings | Commercial, technical, legal and financial findings, and open items. |
| Risks and mitigation | Including conflict, information-sharing and competition risks. |
| Follow-on plan | How the parent will support the company and a reserve for later rounds. |
Table 3. TURN8 editorial guide. Not a published standard.
Two further points. The PitchBook note relayed by the European Business Angels Network calls this a “CVC paradox”: US CVCs invest heavily, but few of their investments end in an acquisition by the sponsor. A team that expects to buy its portfolio should say so in the memo and test it. Second, once a deal closes, the seat and information rules in our guide to CVC board seats and observer roles apply, and the portfolio work is covered in turning a CVC portfolio into strategic value. If you are still setting up the unit, start with how to launch a corporate venture capital fund.
The Gulf context
MAGNiTT data reported by Arab News shows Saudi Arabia leading the Middle East in 2025 with US$1.72 billion across 257 deals. A MAGNiTT and stc group report, as relayed by MENA Startup Digest in May 2026, puts corporate-backed investment at about 12% of MENA venture activity against 15% to 17% globally. That is a secondary report, and we have not seen the original. We found no published data on how Gulf corporates co-invest with sovereign funds, or on the speed of corporate decisions, so we make no claim on either.
Where TURN8 fits
TURN8 is a venture operating partner for GCC corporates and sovereign-linked institutions. Its four engines are venture building, corporate venture capital, an AI studio and the TURN8 accelerator. A corporate can work with TURN8 in three ways: Operate For You, where TURN8 designs, builds and operates; Operate With You, a hybrid alongside your teams; or Build to Own, where TURN8 stands up the capability, trains your people and hands over operations. Read about corporate venture capital at TURN8 and the TURN8 method.
For investment teams, TURN8 Academy offers course 202-CVC, CVC Investor Program. TURN8 Academy runs private cohorts for one organization, with up to 20 participants, held on site at your location, usually over one to two days. Courses are taught by operators, and participants receive a certificate of completion and join the alumni community.
Want your investment process stress-tested?
TURN8 can review your screening criteria, scorecard and memo format. Request a Private Briefing or Discuss a Mandate.
Frequently Asked Questions
How does a corporate venture capital team screen startups?
It screens for strategic fit first, then for team, market, product, return and price. Research by Gompers and Lerner found corporate investments perform best when there is strategic overlap with the parent, so the strategic test comes before the standard venture tests.
How do CVC investors measure success?
Most track both financial and strategic measures. A Touchstone survey cited by Global Venturing found 79% of respondents used IRR and 73% used TVPI, alongside strategic measures such as the share of portfolio companies working with the parent and proofs of concept.
Do corporate investors pay higher valuations?
Research suggests they tend to. Gompers and Lerner found a valuation premium for corporate investors, and a GHIF and PitchBook report relayed by Global Venturing found early-stage CVC-backed deals priced at least 100% above market-wide figures from 2016 to 2023. A memo should explain any premium.
What valuation methods are used for early-stage startups?
Common methods are the Berkus method, the Scorecard method, the VC method and comparable deals. Each has limits: Berkus caps near $2.5 million, Scorecard needs regional medians, the VC method depends on exit assumptions and comparables are scarce. Use at least two.
What terms do founders worry about when taking corporate money?
Founders worry about rights of first refusal on a sale, the signal that deters other buyers, information rights that expose data to a potential competitor, and difficulty selling to the parent’s competitors. Softening exclusivity and agreeing an information firewall can help.
What goes into a corporate investment committee memo?
A clear recommendation, the strategic case, the company and market, the financial case with valuation and any premium, diligence findings, risks and a follow-on plan. We found no published standard template, so teams should build their own and keep the strategic and financial cases side by side.
Important information
This article is general information about corporate venture building and corporate venture capital and is not financial, investment, legal or tax advice. Figures are taken from the sources listed below and were checked in October 2026; they may change. Examples and thresholds are illustrative unless stated. Past results do not predict future performance.
Sources
- BCG, How the best corporate venturers keep getting better (22 August 2018).
- Gompers and Lerner, The determinants of corporate venture capital success (NBER Working Paper 6725) (1998; older academic study).
Partner · TURN8
Ahmed Hassan is a Partner at TURN8, the venture operating partner for GCC corporates and sovereign-linked institutions. He leads the firm’s corporate venture offerings, the venture studios, accelerators, and CVC platforms. TURN8 builds and runs for its partners, and owns go-to-market across every engagement.